Skip to Content
  • Revenues ($M)
    $21,662
  • Revenue Percent Change
    8%
  • Profits ($M)
    $6,939
  • Profits Percent Change
    34.5%
  • Assets ($M)
    $71,576
  • Employees
    17,900
  • Market Value — as of March 31, 2016 ($M)
    $112,761
  • Previous Rank
    145
  • Morning Consult Brand Index
    C-

The Thousand Oaks, Calif.-based biotech pharmaceutical company makes drugs that treat patients in 47 countries.

41319CFF-E47E-4BA5-B1B8-ECA4D480B0DFCreated with sketchtool.62900797-6A09-46DF-8323-A45758A81292Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Company Info

CEO
Robert A. Bradway
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
Thousand Oaks, CA
Websitehttp://www.amgen.com
Years on Fortune 500 List17
Employees17,900

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)$21,6628%
Profits ($M)$6,93934.5%
Assets ($M)$71,576-
Total Stockholder Equity ($M)$28,083-
Market Value — as of March 31, 2016 ($M)$112,761-

Profit Ratios

Profit as % of Revenues32%
Profits as % of Assets9.7%
Profits as % of Stockholder Equity24.7%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)9.06
EPS % Change (from 2014)35.2%
EPS % Change (5 year annual rate)13.6%
EPS % Change (10 year annual rate)12%

Total Return

Total Return to Investors (2015)4%
Total Return to Investors (5 year, annualized)26.3%
Total Return to Investors (10 year, annualized)8.4%